Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2012 Feb;76(2):228–235. doi: 10.1111/j.1365-2265.2011.04187.x

Table 1.

Baseline Characteristics

Hypothyroidism Hyperthyroidism p-value
Mean ± SD Mean ± SD
Number of subjects 15 12
Age (yr) 7.9 ± 2.6 8.0 ± 2.2 0.90
Bone age (yr) 6.8 ± 2.2 9.5 ± 1.9 0.002
Gender (% female) 93% 75% 0.29
Height SDS −0.61 ± 1.09 1.58 ± 0.84 <0.0001
Height velocity (cm/yr) 3.5 ± 2.0 10.0 ± 3.2 <0.0001
TSH (mU/L) 107 (31.3,150)* 0.03 (0.02, 0.03)* 0.0002
T3 (nmol/L) 1.61 ± 0.83 9.1 ± 3.61 <0.0001
T4 (nmol/L) 38.6 ± 29.6 248.4 ± 63.1 <0.0001
CNP (pmol/L) 1.1 (0.9,1.6)* 1.8 (1.7, 2.2)* 0.02
CNP SDS −1.08 (−1.48-0.10)* 0.65 (0.15,1.31)* 0.02
NTproCNP (pmol/L) 35.3 (29.2,48.1)* 58.1 (37.8, 76.7)* 0.02
NTproCNP SDS 0.03 (−0.67, 0.90)* 2.28 (1.21,3.51)* 0.03
NTproCNP:CNP 32.2 ± 8.6 31.3 ± 8.7 0.81
BSAP (mcg/L) 59.6 ± 29.3 102.9 ± 21.3 0.0003
IGF-I (nmol/L) 16.6 ± 6.0 18.2 ± 7.0 0.54

Note: Numbers are mean ± SD, except those marked with an asterix, which are median with interquartile range. Significant values in are in bold.